Date of publication: December 3, 2020 Objectives: Evidence summary: High-Flow Nasal Cannula Oxygen Therapy for the Treatment of Acute Hypoxemic Respiratory Failure for COVID-19 Rapid review: High-Flow Nasal Cannula Oxygen Therapy for the Treatment of Acute Hypoxemic Respiratory Failure for COVID-19 HTAC Recommendation Preview:
Extracorporeal Membrane Oxygenation (ECMO) for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)
I. Assessment A. Policy and Research Question Policy Question: Should ECMO for COVID-19 patients with acute respiratory distress syndrome (ARDS) be recommended for use and covered by PhilHealth? Research Questions: Treatment guidelines and evidence synthesis on the use of ECMO Clinical efficacy / effectiveness and safety Among critically ill COVID-19 patients continue reading : Extracorporeal Membrane Oxygenation (ECMO) for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)